| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3474163988bef091f57392c448f942b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_827b3f75783cf437042a2e25a4a796f4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-282 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-282 |
| filingDate |
1997-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_001b55e4ac15bc6d42b1e515da1e8c5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f97709227493b3f2eb319e0b96cf77e4 |
| publicationDate |
1997-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9735598-A1 |
| titleOfInvention |
Pharmaceutical compositions and methods for the manufacture thereof |
| abstract |
Extracts of herbs of the Artemisia family, some of which have been known in traditional medicine to have anti-diabetic effects, are fractionated chromatographically to remove unacceptable mutagenetic properties while retaining effectiveness against Diabetes mellitus. Certain fractions are found to be insulinomemetic while others have glucagon antagonistic properties. Mixtures of such fractions have optimum clinical effect. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2002335689-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005505544-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102004036047-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6893627-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4744081-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03020026-A1 |
| priorityDate |
1996-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |